Myriad Genetics Inc: (NASD: MYGN)
$31.95
-0.29 (-0.90%)
Volume 29,270
May 23 09:36 AM ET
Zacks Rank: 2-Buy 
| #2 |
Cash flow Statements
Annual Cash Flow Statement
Fiscal Year End for MYRIAD GENETICS falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
| 06/30/12 | 06/30/11 | 06/30/10 | 06/30/09 | 06/30/08 | |
|---|---|---|---|---|---|
| Cash Flow From Operations, Investments & Financial Activities |
|||||
| Net Income (Loss) | 112.15 | 100.71 | 152.30 | 84.61 | 47.84 |
| Depreciation/Amortization & Depletion | 9.06 | 7.21 | 7.08 | 9.44 | 8.78 |
| Net Change from Assets/Liabilities | -28.76 | -14.61 | -27.39 | -54.14 | 16.85 |
| Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Activities | 49.38 | 37.44 | 23.09 | 44.12 | 30.25 |
| Net Cash From Operating Activities | 141.84 | 130.75 | 155.08 | 84.04 | 103.73 |
| Property & Equipment | -9.40 | -3.79 | -7.89 | -7.52 | -13.67 |
| Acquisition/ Disposition of Subsidiaries | -8.79 | -79.41 | 0.00 | 0.00 | 0.00 |
| Investments | -2.83 | 30.91 | -68.97 | -196.71 | -17.28 |
| Other Investing Activities | -17.85 | -2.10 | 0.20 | -2.10 | -0.34 |
| Net Cash from Investing Activities | -38.88 | -54.39 | -76.66 | -206.34 | -31.30 |
Uses of Funds
| 06/30/12 | 06/30/11 | 06/30/10 | 06/30/09 | 06/30/08 | |
|---|---|---|---|---|---|
| Cash Flow From Operations, Investments & Financial Activities |
|||||
| Net Income (Loss) | 112.15 | 100.71 | 152.30 | 84.61 | 47.84 |
| Depreciation/Amortization & Depletion | 9.06 | 7.21 | 7.08 | 9.44 | 8.78 |
| Net Change from Assets/Liabilities | -28.76 | -14.61 | -27.39 | -54.14 | 16.85 |
| Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Activities | 49.38 | 37.44 | 23.09 | 44.12 | 30.25 |
| Net Cash From Operating Activities | 141.84 | 130.75 | 155.08 | 84.04 | 103.73 |
| Property & Equipment | -9.40 | -3.79 | -7.89 | -7.52 | -13.67 |
| Acquisition/ Disposition of Subsidiaries | -8.79 | -79.41 | 0.00 | 0.00 | 0.00 |
| Investments | -2.83 | 30.91 | -68.97 | -196.71 | -17.28 |
| Other Investing Activities | -17.85 | -2.10 | 0.20 | -2.10 | -0.34 |
| Net Cash from Investing Activities | -38.88 | -54.39 | -76.66 | -206.34 | -31.30 |
| Issuance (Repurchase) of Capital Stock | -103.43 | -175.43 | -49.08 | 84.20 | 21.87 |
| Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities | 34.19 | 58.83 | 0.00 | -136.13 | 0.00 |
| Net Cash from Financing Activities | -69.24 | -116.59 | -49.08 | -51.92 | 21.87 |
| Effect of Exchange Rate Changes | -0.04 | 0.07 | 0.00 | 0.00 | 0.00 |
| Net Change In Cash & Equivalents | 33.67 | -40.15 | 29.33 | -174.22 | 94.30 |
| Cash at Beginning of Period | 52.68 | 92.84 | 63.51 | 237.73 | 143.43 |
| Cash at End of Period | 86.35 | 52.68 | 92.84 | 63.51 | 237.73 |
| Diluted Net EPS | 1.30 | 1.10 | 1.54 | 0.86 | 0.51 |
